Form 8.3 - [AbbVie. Inc]
August 22 2019 - 11:05AM
Dow Jones News
TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 21(st) August 2019
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,393,099 4.62501%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,393,099 4.62501%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 3,400 67.54
-------------- ----------------------------- -----------------------
Purchase 800 67.54
-------------- ----------------------------- -----------------------
Purchase 1,400 67.54
-------------- ----------------------------- -----------------------
Purchase 20,200 67.54
-------------- ----------------------------- -----------------------
Purchase 2,400 67.54
-------------- ----------------------------- -----------------------
Purchase 1,500 67.54
-------------- ----------------------------- -----------------------
Purchase 356 67.54
-------------- ----------------------------- -----------------------
Purchase 114 67.54
-------------- ----------------------------- -----------------------
Purchase 588 67.54
-------------- ----------------------------- -----------------------
Purchase 400 67.54
-------------- ----------------------------- -----------------------
Purchase 758 67.54
-------------- ----------------------------- -----------------------
Purchase 500 67.53
-------------- ----------------------------- -----------------------
Purchase 52 67.54
-------------- ----------------------------- -----------------------
Purchase 800 67.54
-------------- ----------------------------- -----------------------
Purchase 3,400 67.54
-------------- ----------------------------- -----------------------
Sale 61 67.69
-------------- ----------------------------- -----------------------
Sale 800 67.54
-------------- ----------------------------- -----------------------
Sale 1,500 67.54
-------------- ----------------------------- -----------------------
Sale 1,400 67.54
-------------- ----------------------------- -----------------------
Sale 34,515 67.54
-------------- ----------------------------- -----------------------
Sale 1,978 67.54
-------------- ----------------------------- -----------------------
Sale 2,400 67.54
-------------- ----------------------------- -----------------------
Sale 800 67.54
-------------- ----------------------------- -----------------------
Sale 3,100 67.34
-------------- ----------------------------- -----------------------
Sale 10,200 66.41
-------------- ----------------------------- -----------------------
Transfer In 114,187 N/A
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- ------------------
Date of disclosure 22(nd) August 2019
------------------------------------------------------- ------------------
Contact name Chetan Shah
------------------------------------------------------- ------------------
Telephone number 020 33956564
------------------------------------------------------- ------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- ------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- ------------------
(END) Dow Jones Newswires
August 22, 2019 10:50 ET (14:50 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024